Sanara MedTech (SMTI) Common Equity (2010 - 2026)

Sanara MedTech has reported Common Equity for 17 years, with the latest figure at $7.0 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 80.83% year-over-year to $7.0 million; the trailing twelve-month figure through Mar 2026 stood at $7.0 million (down 80.83% YoY), and the FY2025 full-year result was $5.9 million, down 84.74% from the prior year.
• Common Equity for Q1 2026 stood at $7.0 million, up from $5.9 million in the prior quarter.
• The five-year high for Common Equity was $44.6 million in Q3 2022, with the low at $5.9 million in Q4 2025.
• Historically, Common Equity has averaged $34.1 million across 5 years, with a median of $39.5 million in 2022.
• Annual changes were most pronounced in 2023 — Common Equity surged 45.46% — and 2025, when it plunged 84.74%.
• Sanara MedTech's Common Equity stood at $41.7 million in 2022, then increased by 6.87% to $44.6 million in 2023, then slipped by 12.73% to $38.9 million in 2024, then sank by 84.74% to $5.9 million in 2025, then increased by 18.36% to $7.0 million in 2026.
• The last three Common Equity figures came in at $7.0 million (Q1 2026), $5.9 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.